83 results
Page 2 of 5
POS AM
qm1u kkpj7ly4
11 Aug 22
Prospectus update (post-effective amendment)
4:20pm
424B3
s08tmfj
10 Aug 22
Prospectus supplement
12:00am
424B3
tbnmojs5l3
10 Aug 22
Prospectus supplement
12:00am
8-K
EX-99.1
dmxf6futpw 60
17 Jun 22
Other Events
4:57pm
424B3
83p4576t3q z3
1 Jun 22
Prospectus supplement
4:06pm
424B3
778abmchxcqdsexb60
16 May 22
Prospectus supplement
8:20pm
424B3
4gg2ux22 6z2
3 May 22
Prospectus supplement
4:06pm
POS AM
l2wi rwekcaik
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
424B3
fe6q vdgelb19d9h
28 Dec 21
Prospectus supplement
4:05pm
8-K
EX-99.1
kvkco
28 Dec 21
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
4:01pm
424B3
k47ps ki3w0t5
12 Nov 21
Prospectus supplement
4:45pm